1 xhibits reduced sensitivity to both DIDS and tenidap.

2 cid, UK5099, and the anti-inflammatory agent tenidap.

3 by the anti-inflammatory drugs niflumate and tenidap.

4 d study, 43 HIV-1-infected patients received tenidap (120 mg) or placebo daily for 6 weeks and then c

5 e synthesis of the well-known drug substance tenidap, a nonexpected difference was observed between t

6 eresting papers described further effects of tenidap, a novel NSAID presently in development.

7  first mutation shown to affect the apparent tenidap affinity of NBCe1.

8                               An analogue of tenidap, CP-100,829, was more effective as an inhibitor

9 st to results in arthritis patients, in whom tenidap decreased plasma levels of IL-6 and acute-phase

10                                              Tenidap decreases interleukin (IL)-6, IL-1, and tumor ne

11                                   Therefore, tenidap disrupted CTL-induced IL-1 beta post-translation

12                    Six patients discontinued tenidap due to rash.

13 n of small differences in plasma TNF levels, tenidap had no significant effect on these indices.

14                               The effects of tenidap in HIV-1 infection contrast to results in arthri

15                                              Tenidap's activity was reversible and was not mimicked b

16 sing, and anion transport inhibitors such as tenidap that suppress cytokine processing independently